Can Umbilical Cord Mesenchymal Stem Cells Treatment Be a Hope for Patients with Refractory Crohn’s Disease?

참고문헌 (10)

1. Knights D, "Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome", Gut, 62, pp.1505~1510 (2013)[DOI]
2. 박재준, "Second Korean guidelines for the management of Crohn’s disease", Intestinal research, 15(1), pp.38~67 (2017), 대한장연구학회
3. Hawkey CJ, "Is stem cell therapy ready for prime time in treatment of inflammatory bowel diseases?", Gastroenterology, 152, pp.389~397 (2017)[DOI]
4. Gao F, "Mesenchymal stem cells and immunomodulation: current status and future prospects", Cell Death Dis, 7, pp.e2062~ (2016)[DOI]
5. Gregoire C, "Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases", Aliment Pharmacol Ther, 45, pp.205~221 (2017)[DOI]
6. Jian Zhang, "Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn’s Disease: A Randomized Controlled Clinical Trial", Gut and Liver, 12(1), pp.73~78 (2018), 거트앤리버 소화기연관학회협의회
7. Duijvestein M, "Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study", Gut, 59, pp.1662~1669 (2010)[DOI]
8. Forbes GM, "A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy", Clin Gastroenterol Hepatol, 12, pp.64~71 (2014)[DOI]
9. Mayer L, "Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant crohn's disease: a phase 1 study", Inflamm Bowel Dis, 19, pp.754~760 (2013)[DOI]
10. Lalu MM, "Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials", PLoS One, 7, pp.e47559~ (2012)[DOI]

관련 논문AI추천